RELX Plc
GBFinancials
Valuation Metrics
RELX Plc's Market Cap is $70.88B. At end of 2025 it was $83.46B. Ranked #248 of 3,116 in US market (top 8%), #176 of 1,644 on NYSE (top 11%), #8 of 84 in Media & Entertainment (top 10%) by Market Cap.
Investment Metrics(as of 2026-10-30)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $70.88B | US#248/3,116 Sec#8/84 |
| Revenue | $12.64B | US#480/3,116 Sec#14/84 |
| Net Income | $2.72B | US#269/3,116 Sec#8/84 |
| Total Assets | $19.87B | US#613/3,116 Sec#15/84 |
| Net Assets | $3.19B | US#929/3,116 Sec#26/84 |
| Employees | 37,000 | US#327/3,116 Sec#6/84 |
| Value | ||
| P/E | 26.03x | US#1,395/3,116 Sec#31/84 |
| P/B | 22.24x | US#2,796/3,116 Sec#75/84 |
| PEG | 3.84x | US#1,143/3,116 Sec#20/84 |
| P/S | 5.61x | US#2,351/3,116 Sec#76/84 |
| EV/EBITDA | 16.58x | US#1,633/3,116 Sec#47/84 |
| FCF Yield | 5.31% | US#1,283/3,116 Sec#46/84 |
| Profitability | ||
| ROE | 85.45% | US#39/3,116 Sec#3/84 |
| ROA | 13.70% | US#268/3,116 Sec#11/84 |
| Op. Margin | 31.11% | US#479/3,116 Sec#7/84 |
| Revenue Growth | 1.65% | US#2,065/3,116 Sec#59/84 |
| Earnings Growth | 6.77% | US#1,139/3,116 Sec#20/84 |
| Financial Health | ||
| Debt Ratio | 522.70% | US#2,362/3,116 Sec#66/84 |
| Total Debt | $9.88B | US#412/3,116 Sec#12/84 |
| FCF | $3.76B | US#211/3,116 Sec#7/84 |
| Cash | $176M | US#1,822/3,116 Sec#56/84 |
| Current Ratio | 0.49x | US#2,717/3,116 Sec#79/84 |
| Net Debt/EBITDA | 2.00x | US#1,324/3,116 Sec#37/84 |
| Dividend | ||
| Div. Yield | 2.20% | US#847/3,116 Sec#17/84 |
| Div. Growth | 5.35% | US#785/3,116 Sec#13/84 |
| Performance | ||
| 1Y Return | -9.63% | US#2,207/3,116 Sec#53/84 |
| 1M Return | 20.84% | US#296/3,116 Sec#7/84 |
| From 52W High | -10.48% | US#1,061/3,116 Sec#25/84 |
| 1Y MDD | -37.80% | US#1,807/3,116 Sec#44/84 |
| Trading | ||
| Volume | 2,152,132 shares | US#1,016/3,116 Sec#37/84 |
| Trading Value | $87M | US#1,083/3,116 Sec#29/84 |
| Per Share | ||
| EPS | $1.54 | US#1,491/3,116 Sec#26/84 |
| BPS | $1.80 | US#2,582/3,116 Sec#63/84 |
Company Info
RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.